WallStreetZenWallStreetZen

NASDAQ: EDAP
Edap Tms Sa Stock Forecast, Predictions & Price Target

Analyst price target for EDAP

Based on 1 analyst offering 12 month price targets for Edap Tms Sa.
Min Forecast
$9.00+26.76%
Avg Forecast
$9.00+26.76%
Max Forecast
$9.00+26.76%

Should I buy or sell EDAP stock?

Based on 1 analyst offering ratings for Edap Tms Sa.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EDAP stock forecasts and price targets.

EDAP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-10

1 of 1

Forecast return on equity

Is EDAP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is EDAP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EDAP revenue forecast

What is EDAP's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$70.6M+5.23%
Avg 2 year Forecast
$81.2M+20.88%
Avg 3 year Forecast
$103.2M+53.69%
EDAP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EDAP revenue growth forecast

How is EDAP forecast to perform vs Medical Distribution companies and vs the US market?
Company
14.61%
Industry
5.97%
Market
10.52%
EDAP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EDAP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EDAP vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
EDAP$7.10$9.00+26.76%Strong Buy
ZYXI$12.58$18.00+43.08%Buy
AHG$1.11N/AN/A
OMI$27.95$23.00-17.71%Hold
PDCO$27.79$32.20+15.87%Hold

Edap Tms Sa Stock Forecast FAQ

Is Edap Tms Sa Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EDAP) stock is to Strong Buy EDAP stock.

Out of 1 analyst, 1 (100%) are recommending EDAP as a Strong Buy, 0 (0%) are recommending EDAP as a Buy, 0 (0%) are recommending EDAP as a Hold, 0 (0%) are recommending EDAP as a Sell, and 0 (0%) are recommending EDAP as a Strong Sell.

If you're new to stock investing, here's how to buy Edap Tms Sa stock.

What is EDAP's revenue growth forecast for 2024-2026?

(NASDAQ: EDAP) Edap Tms Sa's forecast annual revenue growth rate of 14.61% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 5.97%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Edap Tms Sa's revenue in 2024 is $65,677,173.On average, 3 Wall Street analysts forecast EDAP's revenue for 2024 to be $2,618,608,931, with the lowest EDAP revenue forecast at $2,447,138,715, and the highest EDAP revenue forecast at $2,828,183,640. On average, 3 Wall Street analysts forecast EDAP's revenue for 2025 to be $3,008,179,181, with the lowest EDAP revenue forecast at $2,857,466,275, and the highest EDAP revenue forecast at $3,132,129,982.

In 2026, EDAP is forecast to generate $3,824,534,574 in revenue, with the lowest revenue forecast at $3,824,534,574 and the highest revenue forecast at $3,824,534,574.

What is EDAP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EDAP) forecast ROA is N/A, which is lower than the forecast US Medical Distribution industry average of N/A.

What is EDAP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EDAP price target, the average EDAP price target is $9.00, with the highest EDAP stock price forecast at $9.00 and the lowest EDAP stock price forecast at $9.00.

The Wall Street analyst predicted that Edap Tms Sa's share price could reach $9.00 by Nov 10, 2024. The average Edap Tms Sa stock price prediction forecasts a potential upside of 26.76% from the current EDAP share price of $7.10.

What is EDAP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EDAP) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.